Price T Rowe Associates Inc Ambrx Biopharma Inc. Transaction History

Price T Rowe Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.3 - $16.6 $1 Million - $1.79 Million	-107,753 Reduced 11.59%	821,564 $9.45 Million
Q2 2023 Aug 14, 2023	BUY	$7.66 - $16.46 $5.51 Million - $11.8 Million	718,690 Added 341.21%	929,317 $15.3 Million
Q1 2023 May 15, 2023	BUY	$1.46 - $12.54 $307,515 - $2.64 Million	210,627 New	210,627 $1.88 Million

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.